These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31021187)

  • 1. Allele-Specific CRISPR-Cas9 Genome Editing of the Single-Base P23H Mutation for Rhodopsin-Associated Dominant Retinitis Pigmentosa.
    Li P; Kleinstiver BP; Leon MY; Prew MS; Navarro-Gomez D; Greenwald SH; Pierce EA; Joung JK; Liu Q
    CRISPR J; 2018 Feb; 1(1):55-64. PubMed ID: 31021187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cas9/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery.
    Giannelli SG; Luoni M; Castoldi V; Massimino L; Cabassi T; Angeloni D; Demontis GC; Leocani L; Andreazzoli M; Broccoli V
    Hum Mol Genet; 2018 Mar; 27(5):761-779. PubMed ID: 29281027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina.
    Latella MC; Di Salvo MT; Cocchiarella F; Benati D; Grisendi G; Comitato A; Marigo V; Recchia A
    Mol Ther Nucleic Acids; 2016 Nov; 5(11):e389. PubMed ID: 27874856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice.
    Yan Z; Yao Y; Li L; Cai L; Zhang H; Zhang S; Xiao Q; Wang X; Zuo E; Xu C; Wu J; Yang H
    Mol Ther Nucleic Acids; 2023 Sep; 33():750-761. PubMed ID: 37621413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3.
    Diakatou M; Dubois G; Erkilic N; Sanjurjo-Soriano C; Meunier I; Kalatzis V
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele-specific gene-editing approach for vision loss restoration in
    Liu X; Qiao J; Jia R; Zhang F; Meng X; Li Y; Yang L
    Elife; 2023 Jun; 12():. PubMed ID: 37272616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic form of rhodopsin DNA nanoparticles rescued autosomal dominant Retinitis pigmentosa in the P23H knock-in mouse model.
    Mitra RN; Zheng M; Weiss ER; Han Z
    Biomaterials; 2018 Mar; 157():26-39. PubMed ID: 29232624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele-Specific Inhibition of Rhodopsin With an Antisense Oligonucleotide Slows Photoreceptor Cell Degeneration.
    Murray SF; Jazayeri A; Matthes MT; Yasumura D; Yang H; Peralta R; Watt A; Freier S; Hung G; Adamson PS; Guo S; Monia BP; LaVail MM; McCaleb ML
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6362-75. PubMed ID: 26436889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR DNA Base Editing Strategies for Treating Retinitis Pigmentosa Caused by Mutations in
    Kaukonen M; McClements ME; MacLaren RE
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation-Independent Allele-Specific Editing by CRISPR-Cas9, a Novel Approach to Treat Autosomal Dominant Disease.
    Christie KA; Robertson LJ; Conway C; Blighe K; DeDionisio LA; Chao-Shern C; Kowalczyk AM; Marshall J; Turnbull D; Nesbit MA; Moore CBT
    Mol Ther; 2020 Aug; 28(8):1846-1857. PubMed ID: 32416058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV-CRISPR/Cas9 Gene Editing Preserves Long-Term Vision in the P23H Rat Model of Autosomal Dominant Retinitis Pigmentosa.
    Shahin S; Xu H; Lu B; Mercado A; Jones MK; Bakondi B; Wang S
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa.
    Tsai YT; Wu WH; Lee TT; Wu WP; Xu CL; Park KS; Cui X; Justus S; Lin CS; Jauregui R; Su PY; Tsang SH
    Ophthalmology; 2018 Sep; 125(9):1421-1430. PubMed ID: 29759820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dark rearing rescues P23H rhodopsin-induced retinal degeneration in a transgenic Xenopus laevis model of retinitis pigmentosa: a chromophore-dependent mechanism characterized by production of N-terminally truncated mutant rhodopsin.
    Tam BM; Moritz OL
    J Neurosci; 2007 Aug; 27(34):9043-53. PubMed ID: 17715341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa.
    Burnight ER; Wiley LA; Mullin NK; Adur MK; Lang MJ; Cranston CM; Jiao C; Russell SR; Sohn EH; Han IC; Ross JW; Stone EM; Mullins RF; Tucker BA
    CRISPR J; 2023 Dec; 6(6):502-513. PubMed ID: 38108516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant rhodopsin transgene expression on a null background.
    Frederick JM; Krasnoperova NV; Hoffmann K; Church-Kopish J; Rüther K; Howes K; Lem J; Baehr W
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):826-33. PubMed ID: 11222546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.
    Shin JW; Kim KH; Chao MJ; Atwal RS; Gillis T; MacDonald ME; Gusella JF; Lee JM
    Hum Mol Genet; 2016 Oct; 25(20):4566-4576. PubMed ID: 28172889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic and phenotypic characterization of P23H line 1 rat model.
    Orhan E; Dalkara D; Neuillé M; Lechauve C; Michiels C; Picaud S; Léveillard T; Sahel JA; Naash MI; Lavail MM; Zeitz C; Audo I
    PLoS One; 2015; 10(5):e0127319. PubMed ID: 26009893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa.
    Olsson JE; Gordon JW; Pawlyk BS; Roof D; Hayes A; Molday RS; Mukai S; Cowley GS; Berson EL; Dryja TP
    Neuron; 1992 Nov; 9(5):815-30. PubMed ID: 1418997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa.
    Diakatou M; Manes G; Bocquet B; Meunier I; Kalatzis V
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126147
    [No Abstract]   [Full Text] [Related]  

  • 20. Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa.
    Berger A; Lorain S; Joséphine C; Desrosiers M; Peccate C; Voit T; Garcia L; Sahel JA; Bemelmans AP
    Mol Ther; 2015 May; 23(5):918-930. PubMed ID: 25619725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.